Name: UMIN ID:
Unique ID issued by UMIN | UMIN000034869 |
---|---|
Receipt number | R000039604 |
Scientific Title | A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of two dose levels of BCX7353 as an oral treatment for the prevention of attacks in subjects with hereditary angioedema |
Date of disclosure of the study information | 2018/11/13 |
Last modified on | 2021/10/28 14:42:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/11/12 19:58:12 | ||
2 | Update | 2018/11/13 17:34:08 | Classification by specialty |
|
3 | Update | 2018/11/14 07:35:19 | Division Nationality of Funding Organization Nationality of Funding Organization Research ethics review Institutions |
|
4 | Update | 2018/12/06 21:16:50 | Institutions |
|
5 | Update | 2019/03/26 17:50:11 | Recruitment status Date of IRB |
|
6 | Update | 2019/05/14 18:27:12 | 1st name of lead principal investigator 1st name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Division name Division name Organization Organization Address Address Tel |
|
7 | Update | 2019/10/30 07:40:34 | UMIN ID1 |
|
8 | Update | 2020/11/03 13:33:55 | UMIN ID2 |
|
9 | Update | 2020/11/05 00:50:41 | Narrative objectives1 Narrative objectives1 |
|
10 | Update | 2020/11/05 15:14:31 | Last name of contact person Last name of contact person Organization Organization Zip code Address Address TEL Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Organization1 Address1 Tel1 Email1 |
|
11 | Update | 2020/11/05 16:47:35 | Address |
|
12 | Update | 2020/11/05 16:49:27 | Address |
|
13 | Update | 2020/11/27 16:30:26 | Recruitment status Last follow-up date |
|
14 | Update | 2021/06/23 11:47:04 | Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information TEL |
|
15 | Update | 2021/10/28 14:42:01 | Recruitment status |
|
16 | Update | 2021/10/28 14:42:36 | Publication of results URL related to results and publications Number of participants that the trial has enrolled |